Evidence map›Paper›PMID 35858913›Full record

ArticleNature communications2022

Neuropilin 1 and its inhibitory ligand mini-tryptophanyl-tRNA synthetase inversely regulate VE-cadherin turnover and vascular permeability.

Noemi Gioelli, Lisa J Neilson, Na Wei, Giulia Villari, Wenqian Chen, Bernhard Kuhle, Manuel Ehling, Federica Maione, Sander Willox, Serena Brundu and 8 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Molecular Mechanisms Regulating Vascular Endothelial Permeability.International journal of molecular sciences · 2024
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. The blood-brain barrier: structure, regulation, and drug delivery.Signal transduction and targeted therapy · 2023
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 4 countries.

Noemi GioelliDepartment of Oncology, University of Torino School of Medicine, Candiolo (TO), Italy.ORCID 0000-0002-4982-8410
Lisa J NeilsonCancer Research UK Beatson Institute, Glasgow, UK.
Na WeiDepartment of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, 92037, USA.
Giulia VillariDepartment of Oncology, University of Torino School of Medicine, Candiolo (TO), Italy.ORCID 0000-0002-4811-3990
Wenqian ChenDepartment of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, 92037, USA.
Bernhard KuhleDepartment of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, 92037, USA.ORCID 0000-0002-0501-1150
Manuel EhlingCenter for Cancer Biology, Department of Oncology, University of Leuven, Leuven, 3000, Belgium.
Federica MaioneDepartment of Oncology, University of Torino School of Medicine, Candiolo (TO), Italy.
Sander WilloxCenter for Cancer Biology, Department of Oncology, University of Leuven, Leuven, 3000, Belgium.ORCID 0000-0001-6478-448X
Serena BrunduCandiolo Cancer Institute - Fondazione del Piemonte per l'Oncologia (FPO) Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Candiolo (TO), Italy.ORCID 0000-0003-4468-7492
Daniele AvanzatoDepartment of Oncology, University of Torino School of Medicine, Candiolo (TO), Italy.
Grigorios KoulourasCancer Research UK Beatson Institute, Glasgow, UK.ORCID 0000-0002-1180-1730
Massimiliano MazzoneCenter for Cancer Biology, Department of Oncology, University of Leuven, Leuven, 3000, Belgium.ORCID 0000-0001-8824-4015
Enrico GiraudoCandiolo Cancer Institute - Fondazione del Piemonte per l'Oncologia (FPO) Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Candiolo (TO), Italy.ORCID 0000-0003-4128-4786
Xiang-Lei YangDepartment of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, 92037, USA.
Donatella ValdembriDepartment of Oncology, University of Torino School of Medicine, Candiolo (TO), Italy.ORCID 0000-0003-4590-417X
Sara ZanivanCancer Research UK Beatson Institute, Glasgow, UK. S.Zanivan@beatson.gla.ac.uk.ORCID 0000-0002-9880-9099
Guido SeriniDepartment of Oncology, University of Torino School of Medicine, Candiolo (TO), Italy. guido.serini@ircc.it.ORCID 0000-0002-3502-8367
Candiolo Cancer Institute · ITScripps Research Institute · USVIB-KU Leuven Center for Cancer Biology · BECancer Research UK Scotland Institute · GBBeatson West of Scotland Cancer Centre · GB

Funding

Link extracellular function of tRNA synthetase with pathological mechanism of diseaseR35GM139627 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI YANG, XIANG-LEI · 2021 to 2025
$2.3M
Cancer Research UK 29800Cancer Research UK A18076Cancer Research UK A29800Cancer Research UK A31287NIGMS NIH HHS R35 GM139627
6 · The paper itself

Abstract

The formation of a functional blood vessel network relies on the ability of endothelial cells (ECs) to dynamically rearrange their adhesive contacts in response to blood flow and guidance cues, such as vascular endothelial growth factor-A (VEGF-A) and class 3 semaphorins (SEMA3s). Neuropilin 1 (NRP1) is essential for blood vessel development, independently of its ligands VEGF-A and SEMA3, through poorly understood mechanisms. Grounding on unbiased proteomic analysis, we report here that NRP1 acts as an endocytic chaperone primarily for adhesion receptors on the surface of unstimulated ECs. NRP1 localizes at adherens junctions (AJs) where, interacting with VE-cadherin, promotes its basal internalization-dependent turnover and favors vascular permeability initiated by histamine in both cultured ECs and mice. We identify a splice variant of tryptophanyl-tRNA synthetase (mini-WARS) as an unconventionally secreted extracellular inhibitory ligand of NRP1 that, by stabilizing it at the AJs, slows down both VE-cadherin turnover and histamine-elicited endothelial leakage. Thus, our work shows a role for NRP1 as a major regulator of AJs plasticity and reveals how mini-WARS acts as a physiological NRP1 inhibitory ligand in the control of VE-cadherin endocytic turnover and vascular permeability.

Indexed as

Neuropilin-1Tryptophan-tRNA LigaseAdherens JunctionsAnimalsAntigens, CDCadherin 5CadherinsCapillary PermeabilityEndothelial CellsHistamineLigandsMiceProteomicsVascular Endothelial Growth Factor AAntigens, CDCadherin 5CadherinsHistamineLigandsNeuropilin-1Tryptophan-tRNA LigaseVascular Endothelial Growth Factor A

Identifiers

PMID35858913
PMCPMC9300702
OpenAlexW4286210212

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.